Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Comparison of methods to analyse susceptibility of German MDR/XDR Pseudomonas aeruginosa to ceftazidime/avibactam.

Schaumburg F, Bletz S, Mellmann A, Becker K, Idelevich EA.

Int J Antimicrob Agents. 2019 Aug;54(2):255-260. doi: 10.1016/j.ijantimicag.2019.05.001. Epub 2019 May 7.

2.

How to accelerate antimicrobial susceptibility testing.

Idelevich EA, Becker K.

Clin Microbiol Infect. 2019 May 2. pii: S1198-743X(19)30203-4. doi: 10.1016/j.cmi.2019.04.025. [Epub ahead of print] Review.

PMID:
31055166
3.

Fungal prosthetic joint infection in total hip or knee arthroplasty: a retrospective single-centre study of 26 cases.

Theil C, Schmidt-Braekling T, Gosheger G, Idelevich EA, Moellenbeck B, Dieckmann R.

Bone Joint J. 2019 May;101-B(5):589-595. doi: 10.1302/0301-620X.101B5.BJJ-2018-1227.R2.

PMID:
31038988
4.

Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey.

Idelevich EA, Seifert H, Sundqvist M, Scudeller L, Amit S, Balode A, Bilozor A, Drevinek P, Kocak Tufan Z, Koraqi A, Lamy B, Mareković I, Miciuleviciene J, Müller Premru M, Pascual A, Pournaras S, Saegeman V, Schønheyder HC, Schrenzel J, Strateva T, Tilley R, Wiersinga WJ, Zabicka D, Carmeli Y, Becker K; ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES).

Clin Microbiol Infect. 2019 Apr 10. pii: S1198-743X(19)30143-0. doi: 10.1016/j.cmi.2019.03.024. [Epub ahead of print]

PMID:
30980927
5.

In Vitro Activity of the Bacteriophage Endolysin HY-133 against Staphylococcus aureus Small-Colony Variants and Their Corresponding Wild Types.

Schleimer N, Kaspar U, Knaack D, von Eiff C, Molinaro S, Grallert H, Idelevich EA, Becker K.

Int J Mol Sci. 2019 Feb 7;20(3). pii: E716. doi: 10.3390/ijms20030716.

6.

Rapid Detection of Extended-Spectrum β-Lactamases (ESBL) and AmpC β-Lactamases in Enterobacterales: Development of a Screening Panel Using the MALDI-TOF MS-Based Direct-on-Target Microdroplet Growth Assay.

Correa-Martínez CL, Idelevich EA, Sparbier K, Kostrzewa M, Becker K.

Front Microbiol. 2019 Jan 24;10:13. doi: 10.3389/fmicb.2019.00013. eCollection 2019.

7.

New Microbiological Techniques in the Diagnosis of Bloodstream Infections.

Idelevich EA, Reischl U, Becker K.

Dtsch Arztebl Int. 2018 Dec 7;115(49):822-832. doi: 10.3238/arztebl.2018.0822. Review.

8.

Bactericidal activity of bacteriophage endolysin HY-133 against Staphylococcus aureus in comparison to other antibiotics as determined by minimum bactericidal concentrations and time-kill analysis.

Knaack D, Idelevich EA, Schleimer N, Molinaro S, Kriegeskorte A, Peters G, Becker K.

Diagn Microbiol Infect Dis. 2019 Apr;93(4):362-368. doi: 10.1016/j.diagmicrobio.2018.11.005. Epub 2018 Nov 20.

PMID:
30554844
9.

The 24-h clinical microbiology service is essential for patient management.

Blondeau JM, Idelevich EA.

Future Microbiol. 2018 Nov;13:1625-1628. doi: 10.2217/fmb-2018-0228. Epub 2018 Nov 14. No abstract available.

10.

Rapid Direct Susceptibility Testing from Positive Blood Cultures by the Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Direct-on-Target Microdroplet Growth Assay.

Idelevich EA, Storck LM, Sparbier K, Drews O, Kostrzewa M, Becker K.

J Clin Microbiol. 2018 Sep 25;56(10). pii: e00913-18. doi: 10.1128/JCM.00913-18. Print 2018 Oct.

11.

Comparison of tigecycline susceptibility testing methods for multidrug-resistant Acinetobacter baumannii.

Idelevich EA, Freeborn DA, Seifert H, Becker K.

Diagn Microbiol Infect Dis. 2018 Aug;91(4):360-362. doi: 10.1016/j.diagmicrobio.2018.03.011. Epub 2018 Mar 24.

PMID:
29778562
12.

The Novel Phage-Derived Antimicrobial Agent HY-133 Is Active against Livestock-Associated Methicillin-Resistant Staphylococcus aureus.

Kaspar U, de Haro Sautto JA, Molinaro S, Peters G, Idelevich EA, Becker K.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00385-18. doi: 10.1128/AAC.00385-18. Print 2018 Jul.

13.

Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.

Idelevich EA, Groß U, Becker K, Bader O.

Diagn Microbiol Infect Dis. 2018 May;91(1):52-54. doi: 10.1016/j.diagmicrobio.2018.01.003. Epub 2018 Jan 9.

PMID:
29422272
14.

Evaluation of a novel optical assay for rapid detection of methicillin-resistant Staphylococcus aureus in liquid culture.

Knaack D, Idelevich EA, Körber-Irrgang B, Kresken M, Becker K.

J Microbiol Methods. 2018 Mar;146:68-70. doi: 10.1016/j.mimet.2018.01.016. Epub 2018 Feb 1.

PMID:
29410104
15.

Increase of zinc resistance in German human derived livestock-associated MRSA between 2000 and 2014.

van Alen S, Kaspar U, Idelevich EA, Köck R, Becker K.

Vet Microbiol. 2018 Feb;214:7-12. doi: 10.1016/j.vetmic.2017.11.032. Epub 2017 Nov 26.

PMID:
29408035
16.

In Vitro Susceptibility of Clinical Staphylococcus aureus Small-Colony Variants to β-Lactam and Non-β-Lactam Antibiotics.

Idelevich EA, Kriegeskorte A, Schleimer N, Peters G, von Eiff C, Becker K.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02532-17. doi: 10.1128/AAC.02532-17. Print 2018 Apr.

17.

Plasmid-Encoded Transferable mecB-Mediated Methicillin Resistance in Staphylococcus aureus.

Becker K, van Alen S, Idelevich EA, Schleimer N, Seggewiß J, Mellmann A, Kaspar U, Peters G.

Emerg Infect Dis. 2018 Feb;24(2):242-248. doi: 10.3201/eid2402.171074.

18.

Rapid in Vitro Quantification of S. aureus Biofilms on Vascular Graft Surfaces.

Herten M, Bisdas T, Knaack D, Becker K, Osada N, Torsello GB, Idelevich EA.

Front Microbiol. 2017 Dec 5;8:2333. doi: 10.3389/fmicb.2017.02333. eCollection 2017.

19.

Evaluation of a Stenotrophomonas maltophilia bacteremia cluster in hematopoietic stem cell transplantation recipients using whole genome sequencing.

Kampmeier S, Pillukat MH, Pettke A, Kossow A, Idelevich EA, Mellmann A.

Antimicrob Resist Infect Control. 2017 Nov 13;6:115. doi: 10.1186/s13756-017-0276-y. eCollection 2017.

20.

Direct determination of carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa from positive blood cultures using laser scattering technology.

Idelevich EA, Hoy M, Knaack D, Görlich D, Peters G, Borowski M, Becker K.

Int J Antimicrob Agents. 2018 Feb;51(2):221-226. doi: 10.1016/j.ijantimicag.2017.10.009. Epub 2017 Oct 27.

PMID:
29111432
21.

Rapid detection of antibiotic resistance by MALDI-TOF mass spectrometry using a novel direct-on-target microdroplet growth assay.

Idelevich EA, Sparbier K, Kostrzewa M, Becker K.

Clin Microbiol Infect. 2018 Jul;24(7):738-743. doi: 10.1016/j.cmi.2017.10.016. Epub 2017 Oct 24.

22.

Comparison of Different Phenotypic Approaches To Screen and Detect mecC-Harboring Methicillin-Resistant Staphylococcus aureus.

Kriegeskorte A, Idelevich EA, Schlattmann A, Layer F, Strommenger B, Denis O, Paterson GK, Holmes MA, Werner G, Becker K.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e00826-17. doi: 10.1128/JCM.00826-17. Print 2018 Jan.

23.

Susceptibility of MDR Pseudomonas aeruginosa to ceftolozane/tazobactam and comparison of different susceptibility testing methods.

Schaumburg F, Bletz S, Mellmann A, Becker K, Idelevich EA.

J Antimicrob Chemother. 2017 Nov 1;72(11):3079-3084. doi: 10.1093/jac/dkx253.

PMID:
28961968
24.

Rapid Phenotypic Detection of Microbial Resistance in Gram-Positive Bacteria by a Real-Time Laser Scattering Method.

Idelevich EA, Hoy M, Görlich D, Knaack D, Grünastel B, Peters G, Borowski M, Becker K.

Front Microbiol. 2017 Jun 14;8:1064. doi: 10.3389/fmicb.2017.01064. eCollection 2017.

25.

Vascular Graft Impregnation with Antibiotics: The Influence of High Concentrations of Rifampin, Vancomycin, Daptomycin, and Bacteriophage Endolysin HY-133 on Viability of Vascular Cells.

Herten M, Idelevich EA, Sielker S, Becker K, Scherzinger AS, Osada N, Torsello GB, Bisdas T.

Med Sci Monit Basic Res. 2017 Jun 27;23:250-257.

26.

Control of Multidrug-Resistant Pseudomonas aeruginosa in Allogeneic Hematopoietic Stem Cell Transplant Recipients by a Novel Bundle Including Remodeling of Sanitary and Water Supply Systems.

Kossow A, Kampmeier S, Willems S, Berdel WE, Groll AH, Burckhardt B, Rossig C, Groth C, Idelevich EA, Kipp F, Mellmann A, Stelljes M.

Clin Infect Dis. 2017 Sep 15;65(6):935-942. doi: 10.1093/cid/cix465.

PMID:
28520856
27.

First description of an Anaerobiospirillum succiniciproducens prosthetic joint infection.

Schaumburg F, Dieckmann R, Schmidt-Bräkling T, Becker K, Idelevich EA.

New Microbes New Infect. 2017 Mar 23;18:1-2. doi: 10.1016/j.nmni.2017.03.001. eCollection 2017 Jul.

28.

Implementation of short incubation MALDI-TOF MS identification from positive blood cultures in routine diagnostics and effects on empiric antimicrobial therapy.

Köck R, Wüllenweber J, Horn D, Lanckohr C, Becker K, Idelevich EA.

Antimicrob Resist Infect Control. 2017 Jan 14;6:12. doi: 10.1186/s13756-017-0173-4. eCollection 2017.

30.

Evaluation of an Automated System for Reading and Interpreting Disk Diffusion Antimicrobial Susceptibility Testing of Fastidious Bacteria.

Idelevich EA, Becker K, Schmitz J, Knaack D, Peters G, Köck R.

PLoS One. 2016 Jul 8;11(7):e0159183. doi: 10.1371/journal.pone.0159183. eCollection 2016.

31.

Staphylococcus aureus-Associated Musculoskeletal Infections.

Idelevich EA, Kreis C, Löffler B, Peters G.

Curr Top Microbiol Immunol. 2017;409:229-261. doi: 10.1007/82_2016_19.

PMID:
27380269
32.

Parallel and cross-resistances of clinical yeast isolates determined by susceptibility pattern analysis.

Schmalreck AF, Willinger B, Idelevich EA, Fegeler C, Lass-Flörl C, Fegeler W, Becker K.

GMS Infect Dis. 2016 Jun 7;4:Doc02. doi: 10.3205/id000020. eCollection 2016.

33.

Multiplex PCR assay underreports true bloodstream infections with coagulase-negative staphylococci in hematological patients with febrile neutropenia.

Reers Y, Idelevich EA, Pätkau H, Sauerland MC, Tafelski S, Nachtigall I, Berdel WE, Peters G, Silling G, Becker K; Molecular Diagnostics of Sepsis Study Group.

Diagn Microbiol Infect Dis. 2016 Aug;85(4):413-5. doi: 10.1016/j.diagmicrobio.2016.04.024. Epub 2016 May 5.

PMID:
27220608
34.

False non-susceptible results of tigecycline susceptibility testing against Enterobacteriaceae by an automated system: a multicentre study.

Idelevich EA, Büsing M, Mischnik A, Kaase M, Bekeredjian-Ding I, Becker K.

J Med Microbiol. 2016 Aug;65(8):877-81. doi: 10.1099/jmm.0.000281. Epub 2016 May 17. No abstract available.

PMID:
27188162
35.

Direct blood culturing on solid medium outperforms an automated continuously monitored broth-based blood culture system in terms of time to identification and susceptibility testing.

Idelevich EA, Grünastel B, Peters G, Becker K.

New Microbes New Infect. 2015 Dec 23;10:19-24. doi: 10.1016/j.nmni.2015.12.004. eCollection 2016 Mar.

36.

The Recombinant Bacteriophage Endolysin HY-133 Exhibits In Vitro Activity against Different African Clonal Lineages of the Staphylococcus aureus Complex, Including Staphylococcus schweitzeri.

Idelevich EA, Schaumburg F, Knaack D, Scherzinger AS, Mutter W, Peters G, Peschel A, Becker K.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2551-3. doi: 10.1128/AAC.02859-15. Print 2016 Apr.

37.

Successful interdisciplinary radical treatment of Mycobacterium fortuitum infection in a lipotourist from Germany after abdominoplasty in Turkey.

Schlarb D, Idelevich EA, Krause-Bergmann A, Stollwerck P.

New Microbes New Infect. 2015 Sep 10;8:21-3. doi: 10.1016/j.nmni.2015.09.003. eCollection 2015 Nov.

38.

Detection of mecA- and mecC-Positive Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates by the New Xpert MRSA Gen 3 PCR Assay.

Becker K, Denis O, Roisin S, Mellmann A, Idelevich EA, Knaack D, van Alen S, Kriegeskorte A, Köck R, Schaumburg F, Peters G, Ballhausen B.

J Clin Microbiol. 2016 Jan;54(1):180-4. doi: 10.1128/JCM.02081-15. Epub 2015 Oct 21.

39.

[Multidrug-resistant bacteria in Germany. The impact of sources outside healthcare facilities].

Idelevich EA, Lanckohr C, Horn D, Wieler LH, Becker K, Köck R.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Jan;59(1):113-23. doi: 10.1007/s00103-015-2261-z. Review. German.

PMID:
26446586
40.

Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA.

Schaumburg F, Peters G, Alabi A, Becker K, Idelevich EA.

J Antimicrob Chemother. 2016 Jan;71(1):41-4. doi: 10.1093/jac/dkv325. Epub 2015 Oct 5.

PMID:
26443816
41.

Identification and Susceptibility Testing From Shortly Incubated Cultures Accelerate Blood Culture Diagnostics at No Cost.

Idelevich EA, Becker K.

Clin Infect Dis. 2016 Jan 15;62(2):268-9. doi: 10.1093/cid/civ824. Epub 2015 Sep 22. No abstract available. Erratum in: Clin Infect Dis. 2016 Apr 15;62(8):1057.

PMID:
26394670
42.

Randomized controlled clinical trial evaluating multiplex polymerase chain reaction for pathogen identification and therapy adaptation in critical care patients with pulmonary or abdominal sepsis.

Tafelski S, Nachtigall I, Adam T, Bereswill S, Faust J, Tamarkin A, Trefzer T, Deja M, Idelevich EA, Wernecke KD, Becker K, Spies C; Molecular Diagnostics of Sepsis Study Group.

J Int Med Res. 2015 Jun;43(3):364-77. doi: 10.1177/0300060514561135. Epub 2015 Apr 24.

PMID:
25911587
43.

Increased Prevalence and Resistance of Important Pathogens Recovered from Respiratory Specimens of Cystic Fibrosis Patients During a Decade.

Raidt L, Idelevich EA, Dübbers A, Küster P, Drevinek P, Peters G, Kahl BC.

Pediatr Infect Dis J. 2015 Jul;34(7):700-5. doi: 10.1097/INF.0000000000000714.

PMID:
25851069
44.

Impact of multiplex PCR on antimicrobial treatment in febrile neutropenia: a randomized controlled study.

Idelevich EA, Silling G, Niederbracht Y, Penner H, Sauerland MC, Tafelski S, Nachtigall I, Berdel WE, Peters G, Becker K; Molecular Diagnostics of Sepsis Study Group.

Med Microbiol Immunol. 2015 Oct;204(5):585-92. doi: 10.1007/s00430-014-0385-7. Epub 2015 Jan 9.

PMID:
25573349
45.

Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2.

Idelevich EA, Grunewald CM, Wüllenweber J, Becker K.

PLoS One. 2014 Dec 9;9(12):e114834. doi: 10.1371/journal.pone.0114834. eCollection 2014.

46.

Acceleration of antimicrobial susceptibility testing of positive blood cultures by inoculation of Vitek 2 cards with briefly incubated solid medium cultures.

Idelevich EA, Schüle I, Grünastel B, Wüllenweber J, Peters G, Becker K.

J Clin Microbiol. 2014 Nov;52(11):4058-62. doi: 10.1128/JCM.02400-14. Epub 2014 Aug 27.

47.

Bacteriophage-based latex agglutination test for rapid identification of Staphylococcus aureus.

Idelevich EA, Walther T, Molinaro S, Li X, Xia G, Wieser A, Peters G, Peschel A, Becker K.

J Clin Microbiol. 2014 Sep;52(9):3394-8. doi: 10.1128/JCM.01432-14. Epub 2014 Jul 16.

48.

Bacterial spectrum and antimicrobial susceptibility patterns in acquired and connatal lacrimal duct stenosis.

Prokosch V, Prokosch JE, Promesberger J, Idelevich EA, Böhm MR, Thanos S, Stupp T.

Curr Eye Res. 2014 Nov;39(11):1069-75. doi: 10.3109/02713683.2014.898312. Epub 2014 Jun 9.

PMID:
24912091
49.

Rapid identification of microorganisms from positive blood cultures by MALDI-TOF mass spectrometry subsequent to very short-term incubation on solid medium.

Idelevich EA, Schüle I, Grünastel B, Wüllenweber J, Peters G, Becker K.

Clin Microbiol Infect. 2014 Oct;20(10):1001-6. doi: 10.1111/1469-0691.12640. Epub 2014 May 15.

50.

Trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus from Germany (2004-2011).

Schaumburg F, Idelevich EA, Peters G, Mellmann A, von Eiff C, Becker K; Study Group.

Clin Microbiol Infect. 2014 Sep;20(9):O554-7. doi: 10.1111/1469-0691.12519. Epub 2014 Jan 23.

Supplemental Content

Loading ...
Support Center